Skip to main content

Andreea Ciudin Mihai

Institutions of which they are part

Main researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Andreea Ciudin Mihai

Institutions of which they are part

Main researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Neuroprotecció mediada per GLP-1: desenvolupament preclínic d'una nova estratègia terapèutica per la retinopatia diabètica

IP: Andreea Ciudin Mihai
Collaborators: -
Funding agency: Associació Catalana de Diabetis
Funding: 10000
Reference: ACD2014-BAS-001
Duration: 04/03/2014 - 03/03/2016

Preventing cardiovascular ischemic events and arresting their consequences in type 2 diabetic population: a multidisciplinary clinical and experimental approach

IP: -
Collaborators: Ignacio Ferreira González, José Antonio Barrabés Riu, Preventing cardiovascular ischemic events and arresting their consequences in type 2 diabetic population: a multidisciplinary c, Joan Montaner Villalonga, Immaculada Raurell Saborit, Joan López Hellin, Antonio González Fernández, Antonia Sambola Ayala, Marta García Ramírez, Joaquin Lopez Soriano, Anna Meseguer Navarro, Antonio Rodríguez Sinovas, Preventing cardiovascular ischemic events and arresting their consequences in type 2 diabetic population: a multidisciplinary c, Rafael Simó Canonge, Preventing cardiovascular ischemic events and arresting their consequences in type 2 diabetic population: a multidisciplinary c, Francesc Moreso Mateos, Cristina Hernández Pascual, Anna Penalba Morenilla, Maria Nieves Martell Pérez-Alcalde, Neus Bellera Gotarda, Natalia Ramos Terrades, Andreea Ciudin Mihai, Maria Mar Hernandez Guillamon, Preventing cardiovascular ischemic events and arresting their consequences in type 2 diabetic population: a multidisciplinary c, Meritxell Ibernon Vilaró, Ignasi Barba Vert, Jordi Bañeras Rius, Bruno García del Blanco, Daniel Serón Micas, María Eugenia Espinel Garuz, Marisol Ruiz Meana, Maria Pilar Delgado Martínez, Preventing cardiovascular ischemic events and arresting their consequences in type 2 diabetic population: a multidisciplinary c, Irina Betsabe Torres Rodriguez, Javier Inserte Igual, Anna Rosell Novel, Olga Simó Servat, Joan Genescà Ferrer, Mònica Pons Delgado, M Antonieta Azancot Rivero, Maria Nazarena Pizzi, M Antonieta Azancot Rivero
Funding agency: Instituto de Salud Carlos III
Funding: 825000
Reference: PIE13/00027
Duration: 01/01/2014 - 30/06/2018

PREventive Care Infrastructure based On Ubiquitous Sensing (Precious) Grant Agreement nº 611366

IP: Pilar Lusilla Palacios
Collaborators: Andreea Ciudin Mihai, Carmina Castellano Tejedor
Funding agency: EUROPEAN COMMISSION
Funding: 214860
Reference: PRECIOUS_FP7ICT2013
Duration: 01/11/2013 - 31/10/2016

Estudio de los efectos negativos de la diabetes Mellitus tipo 2 sobre la función pulmonar y la respiración durante el sueño (estudio Sweet Lung)

IP: -
Collaborators: Odile Romero Santo-Tomas, Gabriel Sampol Rubio, Andreea Ciudin Mihai, Olga Mestres Soler
Funding agency: Instituto de Salud Carlos III
Funding: 133705
Reference: PI12/00803
Duration: 01/01/2013 - 31/12/2015

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

This investment from EIT Health in the project will enable D-Sight to progress in the clinical development of its groundbreaking treatment for the early stages of diabetic retinopathy.

This initiative of the ”la Caixa” Foundation offers the selected entrepreneurial scientists financial support and support through individual mentoring and training.

Related professionals

Gustavo Gimenez

Gustavo Gimenez

Predoctoral researcher
Infectious Diseases
Read more
Jorge Rodrigo Fernandez

Jorge Rodrigo Fernandez

Research technician
Cardiovascular Diseases
Read more
Silvia Alarcón Portabella

Silvia Alarcón Portabella

Research assistant
Read more
Susana González Suárez

Susana González Suárez

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.